http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I677505-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c5a5ce50a29cd5106da549145a5e77d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate | 2014-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1064c411ff1c0c26b4bad1a285678a4d |
| publicationDate | 2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I677505-B |
| titleOfInvention | Anti-CD26 antibody and use thereof |
| abstract | The present invention relates to novel antibodies capable of binding to CD26 and their use as pharmaceuticals. In addition, the present invention provides antibodies to treat and / or prevent Graft-versus-Host Disease (GvHD), treat Aplastic Anemia, and / or promote implantation after hematopoietic stem cell transplantation. In addition, the present invention provides a pharmaceutical composition comprising at least one antibody of the present invention, and a set of components. |
| priorityDate | 2014-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 239.